Intravesical Therapy for Superficial Bladder Carcinoma

Publisher： Karger

E-ISSN： 2296-5262|22|6|462-462

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.22, Iss.6, 2000-01, pp. : 462-462

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Delayed High-Dose Intravesical Epirubicin Therapy of Superficial Bladder Cancer

By  

Urologia Internationalis, Vol. 68, Iss. 4, 2002-05 ,pp. : 216-219

Karger

Access to resources Recommend Favorite

Intravesical Bacillus Calmette-Guérin Therapy for T1 Superficial Bladder Cancer

By  

Urologia Internationalis, Vol. 80, Iss. 1, 2008-01 ,pp. : 74-79

Karger

Access to resources Recommend Favorite

Bacillus Calmette-Guérin versus Gemcitabine for Intravesical Therapy in High-Risk Superficial Bladder Cancer: A Randomised Prospective Study

By  

Urologia Internationalis, Vol. 84, Iss. 1, 2010-02 ,pp. : 23-27

Karger

Access to resources Recommend Favorite

Cytological Changes Induced by Intravesical Bacillus Calmette-Guérin Therapy for Superficial Bladder Cancer

By  

Urologia Internationalis, Vol. 64, Iss. 2, 2000-05 ,pp. : 74-81

Karger

Access to resources Recommend Favorite

Mycotic Aneurysm of the Popliteal Artery as a Complication of Intravesical BCG Therapy for Superficial Bladder Cancer

By  

Urologia Internationalis, Vol. 71, Iss. 4, 2003-11 ,pp. : 430-432

Karger

Access to resources Recommend Favorite